2023 annual financial data
Amylyx Pharmaceuticals 2023 Operating margin
Amylyx Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was 10.19%.
Operating income was 38,802,000 USD and net income was 49,271,000 USD.
Operating cash flow was 11,919,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 380,786,000 USD
- Operating income
- 38,802,000 USD
- Net income
- 49,271,000 USD
- Operating cash flow
- 11,919,000 USD